Literature DB >> 2564323

Effects of regional alpha- and beta-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans.

J M Hodgson1, M D Cohen, S Szentpetery, M D Thames.   

Abstract

Our purpose was to determine if there are basal adrenergic influences on the coronary circulation in humans. We studied 56 patients with denervated hearts after cardiac transplantation and 19 normally innervated patients with angiographically normal coronary arteries. Coronary blood flow velocity was measured during cardiac catheterization with a subselective 3F intracoronary Doppler catheter. Heart rate was controlled by atrial pacing. Epicardial coronary artery diameter was measured by automated analysis of digital coronary angiograms. Coronary flow reserve was assessed by intracoronary papaverine hydrochloride (12 mg) injections. Regional sympathetic blockade was produced by intracoronary injections of phentolamine (3 mg, alpha) and propranolol (2 mg, beta) or metoprolol (3 mg, beta 1). After alpha-blockade, mean arterial pressure fell significantly (p less than 0.05) in both the denervated transplant (-5.8 +/- 1.5%) (mean +/- SEM) and normally innervated patients (-12.6 +/- 3.2%). Reductions in coronary flow velocity also were observed in these groups (-8.2 +/- 2.3% and -9.2 +/- 5.8%, respectively). Calculated coronary vascular resistance was unchanged. Similar changes were seen when patients were pretreated with beta-blockade before alpha-blockade. Nonspecific beta-blockade did not affect mean arterial pressure but decreased coronary velocity (innervated, -11.6 +/- 3.9%; denervated, -9.3 +/- 2.4%) and increased coronary vascular resistance (innervated, 15.4 +/- 6.7%; denervated, 10.2 +/- 3.7%). Coronary vascular resistance did not rise in either group after selective beta 1-blockade with metoprolol. Coronary flow reserve did not change in either patient group after either alpha- or beta-blockade. Changes in epicardial coronary artery diameter were small and generally not significant. These data suggest that alpha-receptor-mediated vascular tone is negligible in both denervated transplant patients and normally innervated patients. Additionally, the increase in vascular resistance after nonselective beta-blockade is the result of direct beta 2 vascular effects. Our data further suggest that there is little adrenergically mediated epicardial artery tone (either humoral or neural) at rest and that maximal vasodilator responses are not limited by adrenergically mediated vasomotor tone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564323     DOI: 10.1161/01.cir.79.4.797

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Impact of alpha- and beta-adrenergic receptor blockers on fractional flow reserve and index of microvascular resistance.

Authors:  Emanuele Barbato; Giovanna Sarno; Catalina Trana Berza; Giuseppe Di Gioia; Jozef Bartunek; Marc Vanderheyden; Luigi Di Serafino; William Wijns; Bruno Trimarco; Bernard De Bruyne
Journal:  J Cardiovasc Transl Res       Date:  2014-11-01       Impact factor: 4.132

2.  Coronary vascular resistance in primary chronic autonomic failure.

Authors:  Sheng-Ting Li; Basil A Eldadah; Yehonatan Sharabi; Sandra Pechnik; David S Goldstein
Journal:  Clin Auton Res       Date:  2006-05-23       Impact factor: 4.435

3.  Patient preparation for nuclear imaging: when should anti-ischemic medications be withheld?

Authors:  Sarkis B Baghdasarian; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

4.  The correlation between SNPs within the gene of adrenergic receptor and neuropeptide Y and risk of cervical vertigo.

Authors:  Jianlong Han; Jinliang Zuo; Dengsong Zhu; Chunzheng Gao
Journal:  J Clin Lab Anal       Date:  2017-12-02       Impact factor: 2.352

Review 5.  Alpha-adrenergic control of coronary circulation in man.

Authors:  C Indolfi; A Rapacciuolo; M Condorelli; M Chiariello
Journal:  Basic Res Cardiol       Date:  1994 Sep-Oct       Impact factor: 17.165

6.  Adrenergically mediated coronary vasoconstriction in patients with syndrome X.

Authors:  P G Camici; P Marraccini; R Gistri; P A Salvadori; O Sorace; A L'Abbate
Journal:  Cardiovasc Drugs Ther       Date:  1994-04       Impact factor: 3.727

7.  β-Adrenergic receptor blockade impairs coronary exercise hyperemia in young men but not older men.

Authors:  Amanda J Ross; Zhaohui Gao; Jonathan P Pollock; Urs A Leuenberger; Lawrence I Sinoway; Matthew D Muller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-19       Impact factor: 4.733

8.  Intravenous phentolamine abolishes coronary vasoconstriction in response to mild central hypovolemia.

Authors:  Zhaohui Gao; Matthew D Muller; Lawrence I Sinoway; Urs A Leuenberger
Journal:  J Appl Physiol (1985)       Date:  2013-12-05

Review 9.  Neuronal control of coronary blood flow.

Authors:  D Baumgart; G Heusch
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

10.  Comparison of nifedipine and metoprolol on collateral coronary blood flow in a swine model of chronic coronary obstruction and acute ischaemia during isoflurane anaesthesia.

Authors:  D C Cheng; M T Jiang; B Asokumar; P Boylen; A Sandler
Journal:  Can J Anaesth       Date:  1996-02       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.